NCT03728972 2025-10-23Study of Pembrolizumab in Patients With Early-Stage NK/T-cell Lymphoma, Nasal TypeMemorial Sloan Kettering Cancer CenterPhase 2 Active not recruiting19 enrolled 9 charts
NCT05578872 2025-08-26A Study of ANV419 Alone or in Combination With Approved Treatment in Patients With Cutaneous Melanoma (OMNIA-1).Anaveon AGPhase 1/2 Completed29 enrolled 15 charts